Syncom Formul.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
12.12
-0.26 (-2.1%)
BSENSE

Mar 13

BSE+NSE Vol: 18.32 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sakar Healthcare
Venus Remedies
Fredun Pharma
Wanbury
Ind-Swift Labs.
Lincoln Pharma.
Syncom Formul.
Fermenta Biotec.
Hester Bios
Bajaj Healthcare
Beta Drugs Ltd

Why is Syncom Formulations (India) Ltd ?

1
Poor long term growth as Net Sales has grown by an annual rate of -63.92% and Operating profit at -50.69% over the last 5 years
2
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 5.44% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -22.36% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Syncom Formul. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Syncom Formul.
-22.36%
-0.59
37.90%
Sensex
1.0%
0.08
12.13%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-63.92%
EBIT Growth (5y)
-50.69%
EBIT to Interest (avg)
27.57
Debt to EBITDA (avg)
0.81
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
10.97
Tax Ratio
24.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.26%
ROCE (avg)
87.40%
ROE (avg)
166.45%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
17
Industry P/E
33
Price to Book Value
3.01
EV to EBIT
14.67
EV to EBITDA
13.60
EV to Capital Employed
4.25
EV to Sales
1.98
PEG Ratio
0.22
Dividend Yield
NA
ROCE (Latest)
26.23%
ROE (Latest)
16.64%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
ROCE(HY)

Highest at 22.06%

OPERATING PROFIT TO NET SALES(Q)

Highest at 18.42%

DEBTORS TURNOVER RATIO(HY)

Highest at 5.04 times

PBDIT(Q)

Highest at Rs 21.21 cr.

PBT LESS OI(Q)

Highest at Rs 19.59 cr.

PAT(Q)

Highest at Rs 18.91 cr.

EPS(Q)

Highest at Rs 0.20

-3What is not working for the Company
NET SALES(Q)

Lowest at Rs 115.14 cr

Loading Valuation Snapshot...

Here's what is working for Syncom Formul.

Operating Profit Margin - Quarterly
Highest at 18.42% and Grown
each quarter in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Operating Profit (PBDIT) - Quarterly
Highest at Rs 21.21 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 19.59 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 19.59 cr has Grown at 29.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 15.15 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 18.91 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 18.91 cr has Grown at 20.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 15.75 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 0.20
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly
Highest at 5.04 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Syncom Formul.

Net Sales - Quarterly
At Rs 115.14 cr has Fallen at -10.6% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 128.76 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 115.14 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)